Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.50
Bid: 19.10
Ask: 19.48
Change: 0.02 (0.10%)
Spread: 0.38 (1.99%)
Open: 18.80
High: 19.94
Low: 18.80
Prev. Close: 19.48
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of Nanoco 2D Materials Ltd

2 May 2018 07:00

RNS Number : 8009M
Nanoco Group PLC
02 May 2018
 

NANOCO GROUP PLC

("Nanoco" or the "Group")

 

Nanoco Group PLC launches new business, Nanoco 2D Materials Ltd

 

Nanoco 2D Materials Ltd raises seed funding and announces collaboration with The University of Manchester and Nobel Laureate, Professor Konstantin Novoselov

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and nano-materials, announces the launch of Nanoco 2D Materials Ltd "2D Materials", a wholly owned subsidiary focused on the development and commercialisation of a new generation of nano-materials.

Two dimensional nano-particles are a platform technology which are one or two atoms thick and a few nanometres wide and represent a burgeoning field of material science. Currently there is no cost-effective way to produce these 2D materials on a commercial scale nor any reliable method to ensure consistent properties suitable for the wide range of potential electronics, industrial and other applications. 

For the past year Nanoco has been collaborating with Professor Novoselov, 2010 winner of the Nobel Prize for Physics for his work on graphene, with the goal to establish feasibility for these exciting new materials. Based on the positive results seen to date, 2D Materials has been created to formalise the partnership between the two groups, ensure funding is in place and continue the development of the technology.

The £400,000 funding comes from The University of Manchester in the form of a 10-year convertible loan note which carries a 6.5% coupon.

Dr Nigel Pickett, CTO and co-founder of Nanoco, said:

"By combining Nanoco's expertise with the knowledge base from Professor Novoselov's lab we have been able to push the boundaries of material science to come up with a new generation of versatile 2D nano-particles and are now utilising Nanoco's 15 years of scale-up expertise on methods to produce them at commercial scale. Potential commercial applications for these materials span across a wide range of sectors including novel catalysts, photo-detectors, photovoltaics, inverters and light emitting devices."

Professor Novoselov added:

"It is exciting to see how quickly 2D materials, beyond graphene, has accelerated from the early research stage to the technology we now have. Working with a very knowledgeable and dedicated Nanoco team continues to be a very refreshing experience. The ability of our combined teams to focus on particular technological and performance parameters is allowing the rapid development of these 2D Materials."

 Clive Rowland, CEO of the University's innovation company UMI3, commented:

"Part of the University's strategy for commercialising graphene and its sister 2D materials is to work with existing companies and entrepreneurs to help them set-up R&D centres and new companies close to the campus to create a technology innovation ecosystem here - Graphene City®. I'm delighted that we are working with Nanoco, which itself is a spin-out from the University. Its experience in the handling and scaling up of nanomaterials and access to its relevant facilities were key factors in us deciding to support this initiative."

About the convertible note:

The £400,000 funding comes from The University of Manchester in the form of a 10-year convertible loan note which carries a 6.5% coupon. Interest payments are accrued until conversion or repayment of the loan takes place. The loan note is convertible into new shares of 2D Materials and any conversion event is dependent on an additional £1m of third party investment into 2D Materials or sale or flotation of 2D Materials.

 

 

For further information, please contact:

 

Nanoco

Tel: +44 (0) 161 6037900

Michael Edelman, Chief Executive Officer

David Blain, Chief Financial Officer

Caroline Watson, Investor Relations Manager

Tel: + 44 (0) 7799 897357

cwatson@nanocotechnologies.com

Peel Hunt

Tel: +44 (0) 20 7418 8900

Adrian Trimmings

George Sellar

MHP Communications

Tel: +44 (0) 20 3128 8788

Reg Hoare / Giles Robinson / Pete Lambie

nanoco@mhpc.com

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-technology to create a brighter, more sustainable future. Based on breakthrough science, Nanoco's proprietary manufacturing process enables the large-scale production of its cadmium-free CFQD® quantum dots for multiple applications including LCD display, lighting, healthcare, nano-materials and solar.

 

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

 

About UMI3

The University of Manchester I3 Ltd (www.umi3.com) is The University of Manchester's agent for intellectual property commercialisation. UMI3 is wholly owned by the University which has over a 30 year history of IP commercialisation.

UMI3's role is to bring as much of the University's ground-breaking inventions and software, as is relevant, into the commercial world. This we do principally by attracting entrepreneurs, investors and corporate venture partners to our campus and Innovation Centre (www.umic.co.uk) and then, through engagement with our academic colleagues, licensing or spinning out companies.

Since 2004 over 4,000 invention disclosures have been received. UMI3 has set up 41 spin-out companies and 51 social enterprise spin-outs, staff start-ups and assisted student start-ups. Over 7,500 licences and assignments have been brokered and over £360M has been invested by 3rd party venture funders in University of Manchester spin-outs, a number of which have received national and regional enterprise awards. It currently has over 100 projects in its portfolio at various stages of development.

 

The University's IP enterprises have generated over £115M to the University through the sale of shares in spin-outs, licensing income and through IP grants and contracts activity.

For more information, please visit www.umip.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDEASSFELDPEFF
Date   Source Headline
19th Aug 201012:00 pmRNSIssue of Equity
19th Aug 201010:13 amRNSHolding(s) in Company
10th Aug 20107:00 amRNSAppointment of CFO
5th Aug 20107:00 amRNSMilestone Payment
13th Jul 20107:00 amRNSHolding(s) in Company
13th Jul 20107:00 amRNSHolding(s) in Company
10th Jun 20107:00 amRNSSolar Film Agreement
7th May 20103:37 pmRNSHolding(s) in Company
4th May 20104:36 pmRNSHolding(s) in Company
30th Apr 20104:02 pmRNSHolding(s) in Company
28th Apr 20108:34 amRNSHolding(s) in Company
28th Apr 20107:00 amRNSHolding(s) in Company
27th Apr 201011:59 amRNSDirector Share Purchase
30th Mar 20107:01 amRNSAppointment of NED
30th Mar 20107:00 amRNSInterim Results
25th Mar 20107:00 amRNSMilestone Payment
9th Mar 20107:00 amRNSCorporate Broker Appointment
12th Feb 20107:00 amRNSHolding(s) in Company
11th Feb 20108:52 amRNSNotice of Results
11th Feb 20107:00 amRNSNotice of Results
26th Jan 20107:00 amRNSManufacturing Director
19th Jan 20107:00 amRNSHolding(s) in Company
8th Jan 20108:33 amRNSHolding(s) in Company
8th Jan 20108:31 amRNSHolding(s) in Company
24th Dec 200912:20 pmRNSHolding(s) in Company
23rd Dec 200912:29 pmRNSHolding(s) in Company
18th Dec 200911:20 amRNSResult of AGM
18th Dec 20097:00 amRNSAGM Statement
10th Dec 20092:38 pmRNSHolding(s) in Company
30th Nov 20097:00 amRNSGrant of Options
20th Nov 20097:00 amRNSAnnual Report and Accounts
28th Oct 20097:00 amRNSFinal Results
26th Oct 20098:47 amRNSHolding(s) in Company
12th Oct 20097:00 amRNSNotification of Results
23rd Sep 20097:00 amRNSDevelopment Agreement
17th Aug 200910:09 amRNSHolding(s) in Company
21st Jul 20097:42 amRNSHoldings in Company
16th Jul 20092:04 pmRNSHolding(s) in Company
4th Jun 20094:25 pmRNSHolding(s) in Company
5th May 20092:53 pmRNSIssue of Equity
5th May 200910:05 amRNSDirector/PDMR Shareholding
29th Apr 20095:54 pmRNSSchedule 1 Update - Evolutec Group plc
2nd Apr 20093:27 pmRNSSchedule 1 Update - Evolutec Group plc
24th Mar 20094:23 pmRNSResult of GM
19th Mar 20094:43 pmRNSShareholder Notification
2nd Mar 200912:58 pmRNSSchedule 1 - Evolutec Group plc
25th Feb 20091:49 pmRNSFinal Results
25th Feb 20091:40 pmRNSAcquisition
20th Oct 20086:28 pmRNSHolding(s) in Company
9th Sep 200812:47 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.